Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study.

about

Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study.

Item

http://www.wikidata.org/entity/Q50330068

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Spironolactone Treatment and E ...... n: A Propensity-Matched Study.

@en

Spironolactone Treatment and E ...... n: A Propensity-Matched Study.

@nl

type

Item

label

Spironolactone Treatment and E ...... n: A Propensity-Matched Study.

@en

Spironolactone Treatment and E ...... n: A Propensity-Matched Study.

@nl

prefLabel

Spironolactone Treatment and E ...... n: A Propensity-Matched Study.

@en

Spironolactone Treatment and E ...... n: A Propensity-Matched Study.

@nl

P1476

Spironolactone Treatment and E ...... n: A Propensity-Matched Study.

@en

P2093

Bård Waldum-Grevbo

http://www.w3.org/2001/XMLSchema#string

Dan Atar

http://www.w3.org/2001/XMLSchema#string

Ingrid Os

http://www.w3.org/2001/XMLSchema#string

Morten Grundtvig

http://www.w3.org/2001/XMLSchema#string

Viera Stubnova

http://www.w3.org/2001/XMLSchema#string

P2860

A new equation to estimate glomerular filtration rate

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis.

Guidelines for the diagnosis and treatment of chronic heart failure.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Methods to assess intended effects of drug treatment in observational studies are reviewed.

Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.

Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

P304

128-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000454933

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28611786

http://www.w3.org/2001/XMLSchema#string

P932

5465786

http://www.w3.org/2001/XMLSchema#string